Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.

Giuliano AE, Ballman KV, McCall L, Beitsch PD, Brennan MB, Kelemen PR, Ollila DW, Hansen NM, Whitworth PW, Blumencranz PW, Leitch AM, Saha S, Hunt KK, Morrow M.

JAMA. 2017 Sep 12;318(10):918-926. doi: 10.1001/jama.2017.11470.

2.

Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases: Long-term Follow-up From the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 Randomized Trial.

Giuliano AE, Ballman K, McCall L, Beitsch P, Whitworth PW, Blumencranz P, Leitch AM, Saha S, Morrow M, Hunt KK.

Ann Surg. 2016 Sep;264(3):413-20. doi: 10.1097/SLA.0000000000001863.

3.

A Prospective, Single Arm, Multi-site, Clinical Evaluation of a Nonradioactive Surgical Guidance Technology for the Location of Nonpalpable Breast Lesions during Excision.

Cox CE, Russell S, Prowler V, Carter E, Beard A, Mehindru A, Blumencranz P, Allen K, Portillo M, Whitworth P, Funk K, Barone J, Norton D, Schroeder J, Police A, Lin E, Combs F, Schnabel F, Toth H, Lee J, Anglin B, Nguyen M, Canavan L, Laidley A, Warden MJ, Prati R, King J, Shivers SC.

Ann Surg Oncol. 2016 Oct;23(10):3168-74. doi: 10.1245/s10434-016-5405-y. Epub 2016 Jul 28.

PMID:
27469121
4.

Use of hydrogel breast biopsy tissue markers reduces the need for wire localization.

Blumencranz PW, Ellis D, Barlowe K.

Ann Surg Oncol. 2014 Oct;21(10):3273-7. doi: 10.1245/s10434-014-3917-x. Epub 2014 Jul 18.

PMID:
25034819
5.

The clinically negative axilla: The dilemma of occult metastases in sentinel nodes.

Blumencranz PW, Nelson H.

Bull Am Coll Surg. 2012 Jul;97(7):64-5. No abstract available.

PMID:
22834357
6.

Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancer.

Giuliano AE, Hawes D, Ballman KV, Whitworth PW, Blumencranz PW, Reintgen DS, Morrow M, Leitch AM, Hunt KK, McCall LM, Abati A, Cote R.

JAMA. 2011 Jul 27;306(4):385-93. doi: 10.1001/jama.2011.1034.

7.

Molecular analysis of breast sentinel lymph nodes.

Blumencranz PW, Pieretti M, Allen KG, Blumencranz LE.

Surg Oncol Clin N Am. 2011 Jul;20(3):467-85, viii. doi: 10.1016/j.soc.2011.01.002. Review.

PMID:
21640916
8.

Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial.

Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, Leitch AM, Saha S, McCall LM, Morrow M.

JAMA. 2011 Feb 9;305(6):569-75. doi: 10.1001/jama.2011.90.

9.

Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial.

Giuliano AE, McCall L, Beitsch P, Whitworth PW, Blumencranz P, Leitch AM, Saha S, Hunt KK, Morrow M, Ballman K.

Ann Surg. 2010 Sep;252(3):426-32; discussion 432-3. doi: 10.1097/SLA.0b013e3181f08f32.

10.

Adherence to the National Quality Forum (NQF) breast cancer measures within cancer clinical trials: a review from ACOSOG Z0010.

Wilke LG, Ballman KV, McCall LM, Giuliano AE, Whitworth PW, Blumencranz PW, Reintgen DS, Burak WE, Leitch AM, Hunt KK.

Ann Surg Oncol. 2010 Aug;17(8):1989-94. doi: 10.1245/s10434-010-0980-9. Epub 2010 Mar 23.

11.

Special report: Consensus conference III. Image-detected breast cancer: state-of-the-art diagnosis and treatment.

Silverstein MJ, Recht A, Lagios MD, Bleiweiss IJ, Blumencranz PW, Gizienski T, Harms SE, Harness J, Jackman RJ, Klimberg VS, Kuske R, Levine GM, Linver MN, Rafferty EA, Rugo H, Schilling K, Tripathy D, Vicini FA, Whitworth PW, Willey SC.

J Am Coll Surg. 2009 Oct;209(4):504-20. doi: 10.1016/j.jamcollsurg.2009.07.006. Epub 2009 Aug 20. Review. No abstract available. Erratum in: J Am Coll Surg. 2009 Dec;209(6):802. Vicini, Frank A [added].

PMID:
19801324
12.

Impact of immediate versus delayed axillary node dissection on surgical outcomes in breast cancer patients with positive sentinel nodes: results from American College of Surgeons Oncology Group Trials Z0010 and Z0011.

Olson JA Jr, McCall LM, Beitsch P, Whitworth PW, Reintgen DS, Blumencranz PW, Leitch AM, Saha S, Hunt KK, Giuliano AE; American College of Surgeons Oncology Group Trials Z0010 and Z0011.

J Clin Oncol. 2008 Jul 20;26(21):3530-5. doi: 10.1200/JCO.2007.15.5630.

PMID:
18640934
13.

Novel intraoperative molecular test for sentinel lymph node metastases in patients with early-stage breast cancer.

Julian TB, Blumencranz P, Deck K, Whitworth P, Berry DA, Berry SM, Rosenberg A, Chagpar AB, Reintgen D, Beitsch P, Simmons R, Saha S, Mamounas EP, Giuliano A.

J Clin Oncol. 2008 Jul 10;26(20):3338-45. doi: 10.1200/JCO.2007.14.0665.

PMID:
18612150
14.

Scientific Impact Recognition Award. Sentinel node staging for breast cancer: intraoperative molecular pathology overcomes conventional histologic sampling errors.

Blumencranz P, Whitworth PW, Deck K, Rosenberg A, Reintgen D, Beitsch P, Chagpar A, Julian T, Saha S, Mamounas E, Giuliano A, Simmons R.

Am J Surg. 2007 Oct;194(4):426-32.

PMID:
17826050
15.

Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011.

Lucci A, McCall LM, Beitsch PD, Whitworth PW, Reintgen DS, Blumencranz PW, Leitch AM, Saha S, Hunt KK, Giuliano AE; American College of Surgeons Oncology Group.

J Clin Oncol. 2007 Aug 20;25(24):3657-63. Epub 2007 May 7.

PMID:
17485711
16.

Sentinel node skills verification and surgeon performance: data from a multicenter clinical trial for early-stage breast cancer.

Posther KE, McCall LM, Blumencranz PW, Burak WE Jr, Beitsch PD, Hansen NM, Morrow M, Wilke LG, Herndon JE 2nd, Hunt KK, Giuliano AE.

Ann Surg. 2005 Oct;242(4):593-9; discussion 599-602.

17.

Final results of the Department of Defense multicenter breast lymphatic mapping trial.

Shivers S, Cox C, Leight G, Beauchamp D, Blumencranz P, Ross M, Reintgen D.

Ann Surg Oncol. 2002 Apr;9(3):248-55.

PMID:
11923131
18.

The role of lymphoscintigraphy in the management of the patient with breast cancer.

Dupont EL, Kamath VJ, Ramnath EM, Shivers SC, Cox C, Berman C, Leight GS Jr, Ross MI, Blumencranz P, Reintgen DS; DOD Breast Lymphatic Mapping Trial Investigators.

Ann Surg Oncol. 2001 May;8(4):354-60.

PMID:
11352310
19.

Giant cellular blue nevus of the anterior chest wall mimicking metastatic melanoma to the breast: a case report.

Hoos A, Berho M, Blumencranz PW, Brady MS.

J Surg Oncol. 2000 Aug;74(4):278-81.

PMID:
10962460
20.

Scapulectomy for soft tissue sarcoma.

Turnbull A, Blumencranz P, Fortner J.

Can J Surg. 1981 Jan;24(1):37-8.

PMID:
7459733
21.

Cystosarcoma phyllodes. Clinical and pathologic study.

Blumencranz PW, Gray GF.

N Y State J Med. 1978 Mar;78(4):623-7. No abstract available.

PMID:
205817

Supplemental Content

Loading ...
Support Center